R&D
Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
PRODUCTS
MANUFACTURING
NEWS
CONTACT US
ABOUT US
Qilu Launches Generic Aloxi® Injection in the US
Classification:
Company news
Author:
Source:
QILU PHARMACEUTICAL
Release time：
2018/09/19 17:03
Page view
[Abstract]:
Sep. 19, 2018—Qilu Pharmaceutical today announced the U.S. approval and launch of Palonosetron HCl Injection (2.5mg/5ml), a generic version of Aloxi® , which makes the first Day 181 launched product for Qilu in US. Up to now, Qilu has launched ten products in US and among them, eight products are the injectables.
Previous article:
Piperacillin Sodium/Tazobactam Sodium exported to US
NEWS